Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

Torrent Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 28, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	1,739,863	1,428,460	1,094,736	880,347	520,309	473,197
Market Cap Growth	42.97%	30.48%	24.35%	69.20%	9.96%	10.04%
Enterprise Value	1,851,073	1,448,740	1,113,646	917,337	553,029	510,577
Last Close Price	4557.00	4211.83	3193.54	2547.60	1486.94	1327.18

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 28, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	77.31	66.03	57.28	53.15	41.78	60.89
PS Ratio	9.97	10.22	9.51	8.21	5.41	5.56
PB Ratio	9.44	8.12	14.42	12.84	8.40	7.95
P/TBV Ratio	-	-	36.63	45.49	67.48	22.04
P/FCF Ratio	48.64	60.91	55.48	31.07	29.00	29.57
P/OCF Ratio	39.10	47.26	42.35	26.95	21.97	26.25

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 28, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	10.61	10.36	9.67	8.55	5.75	6.00
EV/EBITDA Ratio	32.05	32.22	30.30	27.59	19.73	21.43
EV/EBIT Ratio	47.85	42.12	38.06	35.66	25.84	28.86
EV/FCF Ratio	51.76	61.77	56.44	32.38	30.82	31.90

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 28, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.77	0.85	0.43	0.59	0.87	0.69
Debt / EBITDA Ratio	2.45	3.31	0.88	1.21	1.92	1.70
Debt / FCF Ratio	3.96	6.41	1.65	1.43	3.02	2.57
Net Debt / Equity Ratio	0.61	0.72	0.34	0.44	0.76	0.59
Net Debt / EBITDA Ratio	1.95	2.82	0.70	0.91	1.67	1.48
Net Debt / FCF Ratio	3.12	5.40	1.30	1.07	2.62	2.20
Asset Turnover	0.58	0.47	0.77	0.71	0.68	0.63
Inventory Turnover	1.49	1.19	1.15	1.19	1.17	0.95
Quick Ratio	0.80	0.72	0.62	0.59	0.54	0.56
Current Ratio	1.32	1.13	1.19	1.03	0.98	1.20
Return on Equity (ROE)	15.65%	16.99%	26.46%	25.38%	20.50%	13.18%
Return on Assets (ROA)	8.02%	7.25%	12.17%	10.69%	9.52%	8.14%
Return on Invested Capital (ROIC)	9.64%	12.67%	20.88%	17.43%	14.16%	11.50%
Return on Capital Employed (ROCE)	10.50%	9.60%	28.50%	26.70%	22.40%	20.40%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 28, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	1.29%	1.51%	1.75%	1.88%	2.39%	1.64%
FCF Yield	2.06%	1.64%	1.80%	3.22%	3.45%	3.38%
Dividend Yield	0.83%	0.90%	0.99%	1.08%	1.43%	1.18%
Payout Ratio	69.05%	59.58%	56.67%	61.30%	41.21%	87.10%
Total Shareholder Return	-5.33%	0.90%	0.99%	1.08%	1.43%	1.18%

Data Source: S&P Global Market Intelligence Last updated: Oct 23, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error